Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
354 Leser
Artikel bewerten:
(2)

Beauty-Stem Biomedical (US): Stem-Cell Healthcare New Page: Beauty-Stem Biomedical Launches CD34 Nu-Signals Regenerative Food Supplement

Finanznachrichten News

Epoch-Making Breakthrough of the Stem-Cell Nutritional Supplementation CD34 Nu-Signals®, Currently Undergoing Rigorous Clinical Trials Conducted by Prestigious Medical Institutions to Validate Its Effectiveness

LOS ANGELES / ACCESSWIRE / June 23, 2023 / Beauty-Stem Biomedical, a natural food supplement researcher and supplier, has recently launched its revolutionary product, CD34 Nu-Signals®. This cutting-edge supplement is set to revolutionize the field of stem cell regenerative healthcare with its patented CD34 active protein and MSC exosomes. And it's also the first stem cell food supplement that is undergoing clinical trial with Taipei Tzu Chi Hospital International Medical Service Center.

CD34 Nu-Signals

CD34 Nu-Signals
CD34 Nu-Signals, Currently Undergoing Rigorous Clinical Trials Conducted by Prestigious Medical Institutions to Validate Its Effectiveness

CD34 Nu-Signals® is the result of extensive research and development conducted by Power-Stem Biomedical Research's team of dedicated scientists and researchers. Leveraging their expertise in natural food supplements, the company has created a product that holds immense promise for the advancement of regenerative food supplements.

"The key ingredient of CD34 Nu-Signals® is premium CD34 active protein, which plays a crucial role in the body's natural regenerative processes," said Dr. Chia-Chin Lin, founder of Beauty-Stem Biomedical and Power-Stem Biomedical Research.

The patented micro-liposome technology encapsulates regenerative factors, including GCSF (Granulocyte-Colony Stimulating Factor) and SCF (Stem Cell Factor) proteins. This approach has been proven effective in releasing mature stem cells, promoting autologous rejuvenation and enhancing immunity by numerous international research publications.

CD34 is a surface marker found on certain cells, including hematopoietic stem cells and endothelial progenitor cells. These cells have the remarkable ability to differentiate into various cell types and contribute to tissue repair and regeneration.

In addition to CD34 active protein, CD34 Nu-Signals® also contains MSC-48 exosomes. Mesenchymal stem cell-derived exosomes have gained significant attention in the field of regenerative medicine due to their potential to stimulate tissue repair and modulate the immune system. These tiny vesicles carry a range of bioactive molecules, including proteins, nucleic acids, and growth factors, which can enhance the body's regenerative processes.

By combining CD34 active protein and MSC-48 exosomes, CD34 Nu-Signals® offers a comprehensive approach to stem-cell regenerative healthcare. The supplement is designed to support the body's natural regenerative capabilities and promote optimal tissue healing. It can potentially benefit individuals seeking regenerative solutions for various health concerns.

"We are thrilled to introduce CD34 Nu-Signals® to the market," said Dr. Chia-Chin Lin. "Our team has worked tirelessly to develop a product with natural regenerative mechanisms. CD34 Nu-Signal® has the potential to revolutionize the way we approach regenerative healthcare and provide individuals with a safe and effective solution."

Beauty-Stem Biomedical is constantly pushing boundaries, collaborating with well-known medical centers, including Taipei Tzu Chi Hospital International Medical Service Center, to reach significant milestones in the clinical trials of the effectiveness of CD34 Nu-Signals.

Beauty-Stem Biomedical's commitment to scientific excellence ensures that CD34 Nu-Signals meets the highest standards of efficacy and safety. The company adheres to stringent quality-control processes and sources its ingredients from reputable suppliers.

Contact Information

Ryan Huang
CEO
service.us@beauty-stem.com
888-341-7505

SOURCE: Beauty-Stem Biomedical US

.

View source version on accesswire.com:
https://www.accesswire.com/763529/Stem-Cell-Healthcare-New-Page-Beauty-Stem-Biomedical-Launches-CD34-Nu-Signals-Regenerative-Food-Supplement

© 2023 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.